Protara Therapeutics Inc (TARA)
2.76
0.00 (0.00%)
USD |
NASDAQ |
May 24, 11:28
Protara Therapeutics Cash from Operations (Quarterly): -10.38M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -10.38M |
| December 31, 2023 | -8.70M |
| September 30, 2023 | -6.561M |
| June 30, 2023 | -9.408M |
| March 31, 2023 | -12.89M |
| December 31, 2022 | -5.026M |
| September 30, 2022 | -5.347M |
| June 30, 2022 | -5.123M |
| March 31, 2022 | -10.96M |
| Date | Value |
|---|---|
| December 31, 2021 | -6.907M |
| September 30, 2021 | -6.201M |
| June 30, 2021 | -9.474M |
| March 31, 2021 | -11.92M |
| December 31, 2020 | -6.766M |
| September 30, 2020 | -3.762M |
| June 30, 2020 | -5.733M |
| March 31, 2020 | -7.146M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-12.89M
Minimum
Mar 2023
-3.762M
Maximum
Sep 2020
-7.782M
Average
-6.907M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| AngioDynamics Inc | -12.53M |
| Regulus Therapeutics Inc | -8.742M |
| Bio-Path Holdings Inc | -1.038M |
| Outset Medical Inc | -45.91M |
| NovaBay Pharmaceuticals Inc | -1.572M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 23.10M |
| Cash from Financing (Quarterly) | -0.076M |
| Free Cash Flow | -35.05M |
| Free Cash Flow Per Share (Quarterly) | -0.9088 |
| Free Cash Flow Yield | -111.8% |